SGTX · Categories · Form 3
SGTX - SEC Form 3 initial insider statements
Sigilon Therapeutics Inc. (SGTX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for SGTX
- SEC Form 3: New insider Eli Lilly & Co claimed ownership of 211,110 shares3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
- SEC Form 3: New insider Kowalsky Matthew Paul claimed ownership of 19,683 shares3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
- SEC Form 3 filed by new insider Yuan Qing Sarah3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
- SEC Form 3 filed by new insider Orfali May3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
- SEC Form 3: Pontes Josias claimed ownership of 600 units of Common Stock3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
- SEC Form 3 filed by Story Brooke3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
- SEC Form 3 filed by Ashton-Rickardt Philip3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)